1. Repositório Institucional da UFMG
  2. Publicações Científicas e Culturais
  3. Artigo de Periódico
Please use this identifier to cite or link to this item: http://hdl.handle.net/1843/54522
Full metadata record
DC FieldValueLanguage
dc.creatorRoberto Murillolimongipt_BR
dc.creatorJeremiah Taopt_BR
dc.creatorAndré Borbapt_BR
dc.creatorFilipe Pereirapt_BR
dc.creatorAna Rosa Pimentel de Figueiredopt_BR
dc.creatorPatrícia Akaishipt_BR
dc.creatorAntônio Augusto Velasco e Cruzpt_BR
dc.date.accessioned2023-06-05T19:50:48Z-
dc.date.available2023-06-05T19:50:48Z-
dc.date.issued2016-
dc.citation.volume36pt_BR
dc.citation.issue2pt_BR
dc.citation.spage132pt_BR
dc.citation.epage135pt_BR
dc.identifier.doi10.1093/asj/sjv195pt_BR
dc.identifier.issn1090820Xpt_BR
dc.identifier.urihttp://hdl.handle.net/1843/54522-
dc.description.resumoBackground: Polymethylmethacrylate (PMMA) has been used as an injectable filler to treat hollows and reduce rhytids. PMMA injections have been associated with several side effects, however, the literature is scarce on periorbital complications and their treatments.Objectives: The purpose of this study is to report a series of complications after periorbital PMMA injections to the midface and to describe their management.Methods: Retrospective chart review, including photography and histopathology when available. Results: The authors identified 11 cases of complications of PMMA injections to the midface. Patient ages ranged from 36 to 62 years (mean, 47 years;median, 44 years). Two (18%) were males and 9 (82%) were females. Adverse effects began between 2 to 24 months after injection (mean, 7.2 months;median, 6 months). All patients had edema, erythema, and contour irregularity. Seven (64%) patients had nodules, 4 (36%) had yellow, xanthomatousskin changes, and 2 (18%) had eyelid malposition. Histopathology demonstrated a giant cell inflammation in 5 of 6 cases. Corticosteroid injection was tried in 6 cases but was associated with minimal clinical improvement. Surgical debulking of the implanted material was performed in 9 (82%) cases and was effective in improving edema, erythema, and nodularity.Conclusions: PMMA injection to the midface may be associated with chronic inflammation, fibrotic nodules, yellowing of the skin, and eyelid malposition. Intralesional corticosteroid injections yielded minimal or no improvement; surgical debulking achieved favorable results.pt_BR
dc.format.mimetypepdfpt_BR
dc.languageengpt_BR
dc.publisherUniversidade Federal de Minas Geraispt_BR
dc.publisher.countryBrasilpt_BR
dc.publisher.departmentMED - DEPARTAMENTO DE OFTALMOLOGIA E OTORRINOLARINGOLOGIApt_BR
dc.publisher.initialsUFMGpt_BR
dc.relation.ispartofAesthetic Surgery Journal-
dc.rightsAcesso Abertopt_BR
dc.subjectPolymethylmethacrylatept_BR
dc.subjectAdverse effectspt_BR
dc.subjectInjectionspt_BR
dc.subject.otherPolimetil Metacrilatopt_BR
dc.subject.otherEfeitos Colaterais e Reações Adversas Relacionados a Medicamentospt_BR
dc.subject.otherInjeçõespt_BR
dc.titleComplications and management of polymethylmethacrylate (pmma) injections to the midfacept_BR
dc.typeArtigo de Periódicopt_BR
dc.url.externahttps://doi:10.1093/asj/sjv195pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0002-7569-986Xpt_BR
Appears in Collections:Artigo de Periódico

Files in This Item:
File Description SizeFormat 
Complications and Management of Polymethylemethacrylate PMMA Injections to the Midface pdfa.pdf3.26 MBAdobe PDFView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.